Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 10, 2026

ING rolls out global subscription banking model

View original at globenewswire.com
ING rolls out global subscription banking model ING rolls out global subscription banking model ING today announced a new global subscriptions model designed to make daily banking easier and deliver greater value for customers…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There are already 3 million customers enjoying the benefits of the new subscription plans, including customers migrated from existing offerings

    60% confidence

  • MSCI upgraded ING's ESG rating from 'AA' to 'AAA' in October 2025

    60% confidence

  • ING sees a real opportunity to create value for customers and acted on growing customer demand for simplicity, transparency and lifestyle-aligned benefits

    60% confidence

  • Customers want everyday banking to be simpler, designed around their lifestyle and with more flexibility, based on extensive customer research

    60% confidence

  • The subscription model move marks an important step in ING's strategy to evolve from product-based banking towards more relationship-based customer propositions

    60% confidence

  • ING's customer research shows a growing demand for simplicity, transparency, and benefits that fit everyday life

    60% confidence

  • ING's management of ESG material risk is 'Strong' with an ESG risk rating of 18.0 (low risk)

    60% confidence

  • ING is already seeing strong early interest from customers in the markets where the subscription model has launched

    60% confidence

Data points we hold from this source

ING Group · cash600 USD
ING Group · market share41 millions_customers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
ING rolls out global subscription banking model — Source | Via News | ViaNews Market